Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells

It is not yet clear whether current and emerging biologic strategies to treat musculoskeletal injuries will provide tangible benefits to patients . Platelet-rich plasma (PRP) is used widely despite a lack of evidence supporting its efficacy. Enthusiasm for mesenchymal stem cell (MSC)-based therapies is reflected by the prodigious number […]